A carregar...
Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4
Neuroendocrine prostate cancer (NEPC) is becoming more prevalent as more potent androgen receptor (AR) pathway inhibitors are applied to patients with metastatic tumors. However, there are limited cell and xenograft models currently available, hindering the investigation of signal pathways involved...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5620142/ https://ncbi.nlm.nih.gov/pubmed/28978002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19916 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|